Insider · CIK 0001250195

ELMS STEVE

Reports to the SEC for 21 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001250195

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-06	ADMAADMA BIOLOGICS, INC.P Purchase	Director	PPurchase	+7,000 sh	$15.39	+$108K	2,045,730
2026-03-05	ADMAADMA BIOLOGICS, INC.P Purchase	Director	PPurchase	+7,000 sh	$15.67	+$110K	2,038,730
2026-02-09	ADMAADMA BIOLOGICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+17.7K sh	—	—	17,730
2026-02-09	ADMAADMA BIOLOGICS, INC.A Award	Director	AAward	+10.7K sh	—	—	98,020
2025-11-17	MRKRMarker Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+84.4K sh	—	—	84,411
2025-11-17	MRKRMarker Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+137K sh	—	—	137,330
2025-07-23	Elevation Oncology, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15.6K sh	—	—	0
2025-07-23	Elevation Oncology, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−35K sh	—	—	0
2025-07-23	Elevation Oncology, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−31.2K sh	—	—	0
2025-07-23	Elevation Oncology, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−31.2K sh	—	—	0
2025-07-23	Elevation Oncology, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−35K sh	—	—	0
2025-06-16	ADMAADMA BIOLOGICS, INC.S Sale	Director	SSale	−195K sh	$20.24	−$3.94M	87,330
2025-06-13	ADMAADMA BIOLOGICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−53.2K sh	—	—	0
2025-06-13	ADMAADMA BIOLOGICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−15K sh	—	—	0
2025-06-13	ADMAADMA BIOLOGICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−51.6K sh	—	—	0
2025-06-13	ADMAADMA BIOLOGICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−30K sh	—	—	0
2025-06-13	ADMAADMA BIOLOGICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−37.5K sh	—	—	0
2025-06-13	ADMAADMA BIOLOGICS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+15K sh	$2.92	+$43.7K	222,667
2025-06-13	ADMAADMA BIOLOGICS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+53.8K sh	$3.66	+$197K	160,167
2025-06-13	ADMAADMA BIOLOGICS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+30K sh	$3.89	+$117K	207,667
2025-06-13	ADMAADMA BIOLOGICS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+55K sh	$2.35	+$129K	277,667
2025-06-13	ADMAADMA BIOLOGICS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$5.00	+$50K	106,330
2025-06-13	ADMAADMA BIOLOGICS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+9,000 sh	$5.96	+$53.6K	96,330
2025-06-13	ADMAADMA BIOLOGICS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+51.6K sh	$3.35	+$173K	382,469
2025-06-13	ADMAADMA BIOLOGICS, INC.S Sale	Director	SSale	−138K sh	$20.82	−$2.87M	282,079
2025-06-13	ADMAADMA BIOLOGICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−17.5K sh	—	—	0
2025-06-13	ADMAADMA BIOLOGICS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+17.5K sh	$4.91	+$85.9K	177,667
2025-06-13	ADMAADMA BIOLOGICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−9,000 sh	—	—	0
2025-06-13	ADMAADMA BIOLOGICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	0
2025-06-13	ADMAADMA BIOLOGICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−55K sh	—	—	0
2025-06-13	ADMAADMA BIOLOGICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−53.8K sh	—	—	0
2025-06-13	ADMAADMA BIOLOGICS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+53.2K sh	$1.67	+$88.8K	330,839
2025-06-13	ADMAADMA BIOLOGICS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+37.5K sh	$5.40	+$203K	420,010
2025-06-12	ADMAADMA BIOLOGICS, INC.S Sale	Director	SSale	−92.9K sh	$21.69	−$2.02M	2,031,730
2025-06-05	Elevation Oncology, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+35K sh	—	—	35,000
2025-02-19	ADMAADMA BIOLOGICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+16.3K sh	—	—	16,279
2025-02-19	ADMAADMA BIOLOGICS, INC.A Award	Director	AAward	+10.9K sh	—	—	87,330
2025-02-12	MRKRMarker Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2024-12-23	MRKRMarker Therapeutics, Inc.P Purchase	Director	PPurchase	+11.1K sh	$3.20	+$35.5K	325,370
2024-11-27	ADMAADMA BIOLOGICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−9,000 sh	—	—	0
2024-11-27	ADMAADMA BIOLOGICS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+9,000 sh	$10.80	+$97.2K	2,124,671
2024-06-13	Elevation Oncology, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+35K sh	—	—	35,000
2024-03-19	ADMAADMA BIOLOGICS, INC.S Sale	Director	SSale	−412K sh	$6.08	−$2.5M	2,115,671
2024-03-18	ADMAADMA BIOLOGICS, INC.S Sale	Director	SSale	−49.9K sh	$6.01	−$300K	2,527,500
2024-03-15	ADMAADMA BIOLOGICS, INC.S Sale	Director	SSale	−183K sh	$6.01	−$1.1M	2,577,387
2024-03-14	ADMAADMA BIOLOGICS, INC.S Sale	Director	SSale	−448K sh	$6.05	−$2.71M	2,760,395
2024-03-13	ADMAADMA BIOLOGICS, INC.S Sale	Director	SSale	−407K sh	$6.21	−$2.53M	3,208,671
2024-02-26	ADMAADMA BIOLOGICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+37.5K sh	—	—	37,541
2024-02-26	ADMAADMA BIOLOGICS, INC.A Award	Director	AAward	+24K sh	—	—	76,441
2023-06-06	MRKRMarker Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+8,000 sh	—	—	8,000

Recent filings

Accepted (ET)
Mar 94
ELMS STEVE0001140361-26-008363
SEC(opens sec.gov)
Feb 114
ELMS STEVE0001140361-26-004885
SEC(opens sec.gov)
Nov 194
ELMS STEVE0001104659-25-114081
SEC(opens sec.gov)
Jul 244
ELMS STEVE0001415889-25-020239
SEC(opens sec.gov)
Jun 164
ELMS STEVE0001140361-25-022713
SEC(opens sec.gov)

Insider transactions

Recent filings

Companies

Address